During the past decade, Northside Hospital,125 King Avenue conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northside Hospital,125 King Avenue" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Northside Hospital,125 King Avenue" are "Triple Negative Breast Cancer" (2 trials), "Breast Neoplasms" (1 trials), "Genes, BRCA 1" (1 trials), "Locally Advanced or Metastatic Solid Tumors" (1 trials) and "PD-L1 Negative" (1 trials). Many other conditions were trialed in "Northside Hospital,125 King Avenue" in a lesser frequency.

Most popular intervention types in "Northside Hospital,125 King Avenue" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Sacituzumab Govitecan-hziy" (2 trials) and "nab-Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Northside Hospital,125 King Avenue" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Northside Hospital,125 King Avenue". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Northside Hospital,125 King Avenue, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northside Hospital,125 King Avenue, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".